Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Neurol ; 12(1): 9-15, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15613141

RESUMO

In a randomized prospective multi-centre study, we evaluated the cognitive performances of a group of 41 non-demented patients, all with advanced Parkinson's disease (PD) and a current depressive episode, in whom the effects of pramipexole (PPX) and pergolide (PRG) in an add-on to l-dopa therapy were also studied and published with regard to motor symptoms of PD, motor complications and depression. The Trail Making Test, the Stroop test and four subtests (arithmetic, picture completion, digit symbols and similarities) of the Wechsler Adult Intelligence Scale-Revised were performed prior to and 8 months after the administration of either PPX or PRG. We found no statistically significant difference between the two tested drugs or between the first and the last visit in any of the above-listed neuropsychological tests. All patients' motor outcomes significantly improved and we conclusively demonstrated the anti-depressive effect of PPX. The dissociation of dopaminomimetic effects on the different tested domains indicates that there are different pathological mechanisms of cognitive, motor and affective disturbances in advanced PD patients. In our non-demented group of fluctuating depressed PD subjects, both PPX and PRG administration in combination with l-dopa were safe in terms of the effect on cognitive performance.


Assuntos
Transtornos Cognitivos/tratamento farmacológico , Depressão/tratamento farmacológico , Agonistas de Dopamina/uso terapêutico , Levodopa/uso terapêutico , Doença de Parkinson/tratamento farmacológico , Idoso , Análise de Variância , Transtornos Cognitivos/complicações , Transtornos Cognitivos/psicologia , Depressão/complicações , Depressão/psicologia , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/complicações , Doença de Parkinson/psicologia , Estudos Prospectivos , Estatísticas não Paramétricas
2.
Eur J Neurol ; 10(4): 399-406, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12823492

RESUMO

An 8-month multicentre prospective randomized study aimed at comparing the effects of dopamine receptor agonists pramipexole (PPX; Mirapexin) and pergolide (PRG; Permax) as add-on to L-dopa therapy on depression [Montgomery and Asberg Depression Rating Scale (MADRS)] in 41 non-demented patients (25 men, 16 women) suffering from both mild or moderate depression and advanced Parkinson's disease (PD). The assessment was performed by a blinded independent observer. Motor symptoms (UPDRS III), motor complications (UPDRS IV), activities of daily living (UPDRS II and VI) and depressive symptoms as measured by Self - Rating Depression Scale by Zung were evaluated in an open-label design. The average value of Zung scores decreased significantly in both groups with no statistical difference between both groups. A significant decrease in the average value of MADRS scores was present only in the PPX group. The average UPDRS scores decreased significantly with no statistical difference between both groups at the comparable average total daily dose of both preparations. In both cases, the total daily dose of L-dopa decreased significantly but the decrease was statistically more pronounced in the PRG group. Our results demonstrate the antidepressant effect of PPX in patients with PD while we can't make any conclusions with regard to antidepressant effect of PRG.


Assuntos
Antiparkinsonianos/uso terapêutico , Depressão/tratamento farmacológico , Doença de Parkinson/complicações , Pergolida/uso terapêutico , Tiazóis/uso terapêutico , Atividades Cotidianas , Idoso , Análise de Variância , Antiparkinsonianos/efeitos adversos , Benzotiazóis , Estudos Cross-Over , Depressão/etiologia , Quimioterapia Combinada , Feminino , Humanos , Levodopa/uso terapêutico , Masculino , Pessoa de Meia-Idade , Atividade Motora , Pergolida/efeitos adversos , Placebos , Pramipexol , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Índice de Gravidade de Doença , Método Simples-Cego , Tiazóis/efeitos adversos , Resultado do Tratamento
5.
Biull Eksp Biol Med ; 102(8): 222-4, 1986 Aug.
Artigo em Russo | MEDLINE | ID: mdl-3742038

RESUMO

Cytogenic damages both in the bone marrow (5.5-fold increase in the number of cells with chromosomal aberrations) and in the peripheral blood of mice (4.5-fold increase in the frequency of micronuclear polychromatic erythrocytes and 3-fold rise in the number of micronuclear normochromic erythrocytes, as compared to the control) have been observed after a two-week administration of 0.01% cyclophosphamide with drinking water. The micronuclear test on mature erythrocytes from peripheral blood of mice can be an effective method for the identification of mutagenic properties of the factor under study during its long-term action.


Assuntos
Testes de Mutagenicidade/métodos , Animais , Aberrações Cromossômicas , Eritrócitos/ultraestrutura , Masculino , Camundongos
6.
Genetika ; 16(7): 1307-10, 1980.
Artigo em Russo | MEDLINE | ID: mdl-6778773

RESUMO

The paper contains the results of the study on the frequency of chromosome aberrations in the cell culture of Chinese hamster under a prolonged action of low concentrations of thiophosphamide (Thph). The frequency of chromosome aberrations in the initial period somewhat increases and then keeps to a certain constant level independently on the duration of action of thiophosphamide. With the heightening of the concentration of the chemical, a sharp increase in the number of chromosome aberrations is observed, which leads to a mass dying of the cell culture. These results may be interpreted as the action of the selection against mutant cells.


Assuntos
Aberrações Cromossômicas , Mutagênicos , Tiotepa/efeitos adversos , Animais , Células Cultivadas , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Mutação , Seleção Genética , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...